Johnson Matthey has worked with more than 500 million medical components for “electrophysiology, vascular intervention, cardiac rhythm management, neuromodulation and cochlear therapy areas,” according to its website.
The deal could reach hundreds of millions of dollars, the news outlet reported May 31.
Goldman Sachs Group is teed up to coordinate the purported sale, and neither company commented on the matter.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
